Cecilia Catellani

No ORCID on file · 2 papers in corpus
other 2026
IGF-II, IGFBP-4, -6, and -7, and HMGB1 show changes in follicular fluid in PCOS
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1856759

INTRODUCTION: Polycystic ovary syndrome (PCOS) is a multisystem endocrine and metabolic disease characterized by chronic low-grade inflammation, ovulatory dysfunction, hyperandrogenism, and insulin resistance. Chronic inflammation modifies …

other 2019
MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00879

Objective: MicroRNAs (miRNAs) are gene expression regulators. Altered miRNA levels are associated with diabetes, insulin resistance, and inflammation. Insulin resistance and inflammation are both features of Polycystic ovary syndrome (PCOS)…